Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound

Institutions

Publication Details

Journal
Journal of Medical Biochemistry
Published
2025-01-01
DOI
https://doi.org/10.5937/jomb0-58742
Primary Topic
Chemokine receptors and signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound

Journal of Medical Biochemistry
Chemokine receptors and signaling
article

Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound

article en

Abstract

No abstract available for this paper.
Journal of Medical BiochemistryVol. 44(8)
Jiangsu University (CN), Xuzhou Cancer Hospital (CN), Maternal and Child Health Hospital of Xuzhou (CN)
Openalex Percentile: Top 78%
Chemokine receptors and signaling
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound · Journal of Medical Biochemistry (2025) | TGRS Research Map | TGRS